Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | CASP3 | P42574 | 1/20 | 0.60 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.60 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | EPHX2 | P34913 | 14/20 | 0.58 |
| ▸ | FAAH | O00519 | 4/20 | 0.55 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.51 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17190314 | 0.95 | ALDH1A1 (0.55) | ALDH1A1LMNACASP3SENP8SENP6 | |
| SCHEMBL22563077 | 0.92 | EPHX2 (0.63) | ALDH1A1LMNACASP3SENP8SENP6 | |
| SCHEMBL1977190 | 0.91 | ALDH1A1 (0.70) | ALDH1A1LMNACASP3SENP8SENP6 | |
| SCHEMBL3454901 | 0.86 | SMN1; SMN2 (0.54) | ALDH1A1LMNACASP3SENP8SENP6 | |
| SCHEMBL3453265 | 0.86 | SMN1; SMN2 (0.54) | ALDH1A1LMNACASP3SENP8SENP6 | |
| SCHEMBL13266897 | 0.86 | ALDH1A1 (0.64) | ALDH1A1LMNACASP3SENP8SENP6 | |
| SCHEMBL1028676 | 0.84 | EPHX2 (0.68) | ALDH1A1LMNACASP3SENP8SENP6 | |
| SCHEMBL11755572 | 0.84 | PARP10 (0.71) | ALDH1A1LMNACASP3SENP8SENP6 | |
| SCHEMBL10188548 | 0.83 | ALDH1A1 (0.57) | ALDH1A1LMNACASP3SENP8SENP6 | |
| SCHEMBL9640923 | 0.83 | HRH1 (0.43) | EPHX2PARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090233910-A1 | Npy antagonists, preparation and uses | CEREP (FR) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233910-A1 | Npy antagonists, preparation and uses | NPY1R, NPY5R, NPY2R | ALDH1A1 4542/4885LMNA 2227/4885CASP3 3919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.